Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses (Q28634282)

3 February 2017

title

Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses (English)

1 reference

3 February 2017

0 references

S. Rose-John

0 references

T. Jostock

1 reference

3 February 2017

J. Müllberg

1 reference

3 February 2017

S. Ozbek

1 reference

3 February 2017

R. Atreya

1 reference

3 February 2017

G. Blinn

1 reference

3 February 2017

N. Voltz

1 reference

3 February 2017

M. Fischer

1 reference

3 February 2017

M. F. Neurath

1 reference

3 February 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

3 February 2017

1 reference

3 February 2017

volume

268

1 reference

3 February 2017

1 reference

3 February 2017

page(s)

160–167

1 reference

Gp130 and the interleukin-6 family of cytokines

3 February 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.01867.X

Soluble receptors for cytokines and growth factors: generation and biological function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.01867.X

Neural activities of IL-6-type cytokines often depend on soluble cytokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.01867.X

The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.01867.X

Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.01867.X

Sympathetic neurons can produce and respond to interleukin 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.01867.X

Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.01867.X

gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.01867.X

Cloning and expression of an alternatively spliced mRNA encoding a soluble form of the human interleukin‐6 signal transducer gp1301

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.01867.X

The membrane proximal cytokine receptor domain of the human interleukin-6 receptor is sufficient for ligand binding but not for gp130 association

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.01867.X

Soluble interleukin 6 receptor is biologically active in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.01867.X

The R27080 glycoprotein is abundantly secreted from human cytomegalovirus-infected fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.01867.X

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.01867.X

Receptor recognition sites of cytokines are organized as exchangeable modules. Transfer of the leukemia inhibitory factor receptor-binding site from ciliary neurotrophic factor to interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.01867.X

Blockade of interleukin 6 trans signaling suppresses T-cell resistanceagainst apoptosis in chronic intestinal inflammation: Evidence in Crohn diseaseand experimental colitis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.01867.X

Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.01867.X

The membrane distal half of gp130 is responsible for the formation of a ternary complex with IL-6 and the IL-6 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.01867.X

Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.01867.X

Soluble human interleukin-6 receptor. Expression in insect cells, purification and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.01867.X

Recombinant human single chain Fv antibodies recognizing human interleukin-6. Specific targeting of cytokine-secreting cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.01867.X

Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.01867.X

LIF and OM directly interact with a soluble form of gp130, the IL-6 receptor signal transducing subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.01867.X

CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.01867.X

A possible role for soluble IL-6 receptor in the pathogenesis of systemic onset juvenile chronic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.01867.X

Identification and Characterization of Two Distinct Truncated Forms of gp130 and a Soluble Form of Leukemia Inhibitory Factor Receptor α-Chain in Normal Human Urine and Plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.01867.X